News

InfectoGnostics researchers have developed a test that can detect genetic characteristics of the bacterium Staphylococcus aureus and distinguish between more than 700 strains of this pathogen. Virulence factors and resistance genes, including those of the "multiresistant" variants (MRSA), can be…

Together with its partners, the InfectoGnostics Research Campus participated in the AMR Conference in Basel from April 7 to 8, 2022 and presented scientific results and cooperation concepts from Jena. The AMR Conference is considered one of the most important international conferences that…

InfectoGnostics researchers at Jena University Hospital (JUH) and the Leibniz Institute for Photonic Technology (Leibniz-IPHT) have been able to show how irrelevant human DNA can be sorted out already during sequencing with nanopore systems to enable more precise analyses of microbiomes and bring…

InfectoGnostics scientists at the Leibniz Institute of Photonic Technologies (Leibniz-IPHT), together with partners from the United Arab Emirates (UAE), have successfully validated a lateral flow test that was previously developed together with InfectoGnostics' corporate partners Senova and fzmb. In…

The Cross-Cluster Weeks Thuringia were again a complete success in 2021 with almost 800 participants. Topics like sustainable production, new materials, energy transition, resource efficiency, on-site analysis and therapy of infections or digitalization were discussed in a cross-sectoral exchange…

The central German start-up company "nanozoo" – a member of the InfectoGnostics research campus in Jena – has launched a portal for the free analysis and processing of raw data from the genome sequencing of SARS-CoV-2 isolates. Within a few hours, the data of registered users will be processed and…

An international team of researchers, including two InfectoGnostics partners - the Leibniz Institute for Photonic Technologies (Leibniz-IPHT) in Jena and the diagnostics company Senova in Weimar - has developed a rapid antibody test for the new coronavirus. Using a blood sample, it shows within ten…

The right treatment for the right patient at the right time - this approach of "precision medicine" is increasingly being used in the prevention of infections and sepsis. In an interview with the "Infectious Diseases Hub", Prof. Mathias Pletz, leading infectiologist at the University Hospital of…

The Federal Ministry of Education and Research (BMBF) is funding a new Leibniz Research Centre in Jena. Technology developers, physicians and medical technology manufacturers will bring light-based technologies for better diagnostics and therapy of infections from the idea to the application in the…

One in eight newly hospitalised patients is already a carrier of ESBL-forming bacteria, scientists from the InfectoGnostics Research Campus Jena have now proven in an observational study involving 1,334 patients. Although infections with the patient’s own ESBL pathogens remained an exception in the…